Molecular Diagnosis

, Volume 7, Issue 3, pp 187–194 | Cite as

Monitoring NF-κB Transactivation Potential Via Real-Time PCR Quantification of IκB-α Gene Expression

  • Virginie Bottero
  • Véronique Imbert
  • Catherine Freiin
  • Jean-Louis Formento
  • Jean-François Peyron
Original Research Article


Background: Nuclear factor-kappa B (NF-κB) is an important transcription factor involved in the regulation of immune responses as well as in cell proliferation and survival. An abnormal and constitutive activation of NF-κB is observed in many pathological states as diverse as inflammation, neurological diseases, and cancer.

Methods and results: Termination of NF-κB transcription is mediated through the NF-κB-dependent synthesis of the IκB-α inhibitory subunit. To quantify NF-κB activation we measured by real-time PCR the expression of IκB-α mRNA. The PCR data perfectly matched the results obtained by Northern blot or gene reporter analysis when Jurkat leukemic T cells or HeLa carcinoma cells were stimulated with various activators of NF-κB, such as the cytokine tumor necrosis factor (TNF)-α or the phorbol ester PMA. Constitutive NF-κB activation in Hodgkin’s lymphoma cell line could also be evaluated by this approach. Kinetic experiments in HeLa cells show that TNF stimulation first induced NF-κB DNA binding within 30 minutes, followed by IκB-α gene transcription 30 minutes later. Removal of TNF after stimulation resulted in a faster decrease in both NF-αB DNA binding activity and IκB-α mRNA levels. No accumulation or stabilization of IαB-α mRNA was detected that could bias interpretation of the results. The sensitivity of the method allowed the detection of NF-αB activation in stimulated normal peripheral blood lymphocytes.

Conclusion: The real-time PCR measure of IαB-α mRNA levels is a rapid, sensitive, and powerful method to quantify the transcriptional power of NF-κB. It can be easily used for clinical evaluation of NF-κB status.


Jurkat Cell Electrophoretic Mobility Shift Assay ALLN Inhibitory Subunit GAPDH Copy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work is supported by an institutional grant from INSERM and by a grant from La Fondation de France, Comité Leucémies.

We would like to express our thanks to Mrs Marie Noëlle Monthouel (INSERM U145, Nice) for her help and advice at the beginning of this study. We also thank Dr Gérard Milano (Centre Antoine Lacassagne, Nice, France) for his support.

The authors have no conflict of interest directly relevant to the content of this study.


  1. 1.
    Pahl H. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 1999; 18: 6853–66PubMedCrossRefGoogle Scholar
  2. 2.
    Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immmunol 2000; 18: 621–63CrossRefGoogle Scholar
  3. 3.
    Barnes P, Karin M. Nuclear Factor-kB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–71PubMedCrossRefGoogle Scholar
  4. 4.
    Karin M, Cao Y, Greten F, et al. NF-kB in cancer: from innocent bystander to major culprit: nature reviews. Cancer 2002; 2: 301–10PubMedGoogle Scholar
  5. 5.
    Karin M, Lin A. NF-kB at the crossroads of life and death. Nat Immunol 2002; 3: 221–7PubMedCrossRefGoogle Scholar
  6. 6.
    Delhase M, Hayakawa M, Chen Y, et al. Positive and negative regulation of IkB kinase activity through IKKb subunit phosphorylation. Science 1999; 284: 309–13PubMedCrossRefGoogle Scholar
  7. 7.
    Zabel U, Henkel T, dos Santos Silva M, et al. Nuclear uptake control of NF-kB by MAD-3, an IkB protein present in the nucleus. EMBO J 1993; 12: 201–11PubMedGoogle Scholar
  8. 8.
    Saiki R, Bugawan T, Horn G, et al. Analysis of enzymatically amplified betaglobin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163–6PubMedCrossRefGoogle Scholar
  9. 9.
    Higuchi R, Fockler C, Dollinger G, et al. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 1993; 11: 1026–30PubMedCrossRefGoogle Scholar
  10. 10.
    Sizemore N, Lerner N, Dombrowski N, et al. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa-B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 2002; 8: 3863–9CrossRefGoogle Scholar
  11. 11.
    Zhong H, May M, Jimi E, et al. The phosphorylation status of NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002; 9: 625–36PubMedCrossRefGoogle Scholar
  12. 12.
    Beg AA, Sha WC, Bronson RT, et al. Constitutive NF-kB activation, enhanced granulopoiesis, and neonatal lethality in IkBa-deficient mice. Genes Dev 1995; 9: 2736–46PubMedCrossRefGoogle Scholar
  13. 13.
    Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 1998; 281: 1360–3PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  • Virginie Bottero
    • 1
  • Véronique Imbert
    • 1
  • Catherine Freiin
    • 1
  • Jean-Louis Formento
    • 2
  • Jean-François Peyron
    • 1
  1. 1.Faculty of Medicine PasteurINSERM U526, Hematopolatic Cell Activation, IFR 50Nice Cedex 02France
  2. 2.Laboratory of OncopharmacologyCentre Antoine LacassagneNiceFrance

Personalised recommendations